ATE378328T1 - Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung - Google Patents

Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Info

Publication number
ATE378328T1
ATE378328T1 AT02712114T AT02712114T ATE378328T1 AT E378328 T1 ATE378328 T1 AT E378328T1 AT 02712114 T AT02712114 T AT 02712114T AT 02712114 T AT02712114 T AT 02712114T AT E378328 T1 ATE378328 T1 AT E378328T1
Authority
AT
Austria
Prior art keywords
pyrrolo
prodrugs
indole
tumor treatment
quinoline derivatives
Prior art date
Application number
AT02712114T
Other languages
English (en)
Inventor
Mark Searcey
L Patterson
Original Assignee
Univ London Pharmacy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Pharmacy filed Critical Univ London Pharmacy
Application granted granted Critical
Publication of ATE378328T1 publication Critical patent/ATE378328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02712114T 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung ATE378328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01301636 2001-02-22

Publications (1)

Publication Number Publication Date
ATE378328T1 true ATE378328T1 (de) 2007-11-15

Family

ID=8181737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02712114T ATE378328T1 (de) 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Country Status (7)

Country Link
US (1) US7626026B2 (de)
EP (1) EP1409480B1 (de)
JP (1) JP2004529887A (de)
AT (1) ATE378328T1 (de)
DE (1) DE60223544T2 (de)
ES (1) ES2299560T3 (de)
WO (1) WO2002068412A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192977B2 (en) * 2001-02-22 2007-03-20 School Of Pharmacy Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
GB0505644D0 (en) 2005-03-18 2005-04-27 Univ London Pharmacy Analogues of the azinomycins as anti-tumour agents and as prodrugs
MX2009006880A (es) * 2006-12-22 2009-07-03 Schering Corp Derivados indolicos con anillo unido en las posiciones 4,5 para tratar o prevenir infecciones virales por virus de la hepatitis c e infecciones virales relacionadas.
JP5211068B2 (ja) * 2006-12-22 2013-06-12 メルク・シャープ・アンド・ドーム・コーポレーション Ｈｃｖおよび関連するウイルス疾患の治療または予防のための４，５−環インドール誘導体
CA2674831A1 (en) 2006-12-22 2008-11-13 Schering Corporation 5,6-ring annulated indole derivatives and methods of use thereof
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
EP2197842B1 (de) 2007-08-29 2012-05-23 Schering Corporation 2,3-substituierte indolderivate zur behandlung von virusinfektionen
ES2447543T3 (es) 2007-08-29 2014-03-12 Merck Sharp & Dohme Corp. Derivados de indol sustituidos y métodos de utilización de los mismos
CA2697500A1 (en) 2007-08-29 2009-03-12 Schering Corporation 2,3-substituted azaindole derivatives for treating viral infections
CA2705586A1 (en) 2007-11-16 2009-05-22 Schering Corporation 3-heterocyclic substituted indole derivatives and methods of use thereof
EP2222672B1 (de) 2007-11-16 2013-12-18 Merck Sharp & Dohme Corp. 3-aminosulfonylsubstituierte indolderivate und verfahren zu deren anwendung
WO2009152200A1 (en) 2008-06-13 2009-12-17 Schering Corporation Tricyclic indole derivatives and methods of use thereof
MX2011004625A (es) 2008-11-03 2011-07-20 Syntarga Bv Analogos cc-1065 novedosos y sus conjugados.
CA2956934C (en) 2010-04-21 2019-07-09 Syntarga B.V. Novel conjugates of cc-1065 analogs and bifunctional linkers
US8496218B2 (en) * 2011-06-08 2013-07-30 Alcon Research, Ltd. Display monitor guide
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
GB202300668D0 (en) * 2023-01-17 2023-03-01 Univ Bradford Cancer treating compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
GB2190724B (en) 1986-04-16 1990-08-08 Courtaulds Plc Composite element
FI85403C (fi) 1989-12-22 1992-04-10 Neste Oy Foerfarande foer framstaellning av en plastkompositbalk eller -pelare med staolfoerstaerkningen.
CA2076465C (en) 1992-03-25 2002-11-26 Ravi V. J. Chari Cell binding agent conjugates of analogues and derivatives of cc-1065
FR2700805B1 (fr) 1993-01-27 1995-04-07 Ind Entreprise Procédé de renforcement d'une poutre détériorée, et poutre ainsi obtenue.
US5448869A (en) 1994-02-17 1995-09-12 Marvin Lumber And Cedar Co. Composite framing member and window or door assembly incorporating a composite framing member
US5501054A (en) 1994-03-01 1996-03-26 The United States Of America As Represented By The Secretary Of Agriculture Bolted wood connections
US5720143A (en) 1994-03-01 1998-02-24 The United States Of America As Represented By The Secretary Of Agriculture Localized notch reinforcement for wooden beams
US5679432A (en) 1994-05-09 1997-10-21 Benchmark Foam, Inc. Multi-layer laminate structure
US5688426A (en) 1995-06-07 1997-11-18 The Boeing Company Hybrid metal webbed composite beam
US5657595A (en) 1995-06-29 1997-08-19 Hexcel-Fyfe Co., L.L.C. Fabric reinforced beam and column connections
GB9519490D0 (en) 1995-09-25 1995-11-29 Melvin William T Use of a cytochrome P450 enzyme in tumour cells as a marker and target
EP0888301B1 (de) 1996-03-08 2005-08-10 The Scripps Research Institute Mcbi analoge von cc-1065 und die duocarmycine
US5843937A (en) * 1996-05-23 1998-12-01 Panorama Research, Inc. DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
US6060608A (en) * 1996-05-31 2000-05-09 The Scripps Research Institute Analogs of CC-1065 and the duocarmycins
US5794402A (en) 1996-09-30 1998-08-18 Martin Marietta Materials, Inc. Modular polymer matrix composite support structure and methods of constructing same
JP2002503228A (ja) 1997-05-22 2002-01-29 ザ スクリップス リサーチ インスティテュート デュオカルマイシンおよびｃｃ−１０６５の類似体
DE69918950T2 (de) 1998-02-06 2005-07-28 De Montfort University Durch hydroxylierung aktivierte medikamentvorstufen

Also Published As

Publication number Publication date
ES2299560T3 (es) 2008-06-01
US7626026B2 (en) 2009-12-01
EP1409480A1 (de) 2004-04-21
US20040157873A1 (en) 2004-08-12
WO2002068412A1 (en) 2002-09-06
DE60223544D1 (de) 2007-12-27
JP2004529887A (ja) 2004-09-30
EP1409480B1 (de) 2007-11-14
DE60223544T2 (de) 2008-09-25

Similar Documents

Publication Publication Date Title
DE60223544D1 (de) Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung
ATE327750T1 (de) Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
DE60220057D1 (de) Indoline und tetrahydro-chinoline als prodrugs zur tumorbehandlung
PT2420234E (pt) 1h-benzimidazole-4-carboxamidas substituídas com um carbono quaternário na posição 2 como inibidores de parp para uso no tratamento do cancro
EP4272748A3 (de) Antisense-oligonukleotide zur induzierung von exon-skipping und verfahren zur verwendung davon
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
SG164368A1 (en) Treatment of cancer
MX2009004888A (es) Inhibidores del virus de la hepatitis c.
NZ580226A (en) Dimer compounds as inhibitors of iap
MX2009006864A (es) Inhibidores novedosos de c jun-n-terminal cinasas.
EP1604010A4 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR siRNA-HEMMUNG VON ICAM-1
PT1902037E (pt) 2,4-diamino-pirimidinas como inibidores de aurora
EP3173415A3 (de) Aktivatoren der menschlichen pyruvatkinase
WO2010000364A8 (de) Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate
MX2007003470A (es) Compuestos de carbonilo los cuales pueden utilizarse como inhibidores del factor de coagulacion xa.
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
WO2005086860A3 (en) Methods for generating insulin-producing cells
ATE432922T1 (de) Substituierte 5-carboxyamidpyrazoles und ä1,2, 4ütriazole als viruzide
WO2008152306A3 (fr) Nouveaux substrats de peptidase
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2006035244A3 (en) Ecteinascidin compounds as anti -inflammatory agents
WO2006071966A3 (en) Rapamycin compounds in the treatment of neurofibromatosis type 1
TW200637806A (en) 2-alkylcycloalk(en)ylcarboxamides
MX2007006090A (es) 2-metilen-19-nor-(20r)-1a-hidroxi-bishomopregnacalciferol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties